|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/755 | |
| A61K 38/37 | |||
| A61K 38/48 | |||
| C07K 19/00 |
| (11) | Patento numeris | 2417155 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10715162.3 |
| Europos patento paraiškos padavimo data | 2010-04-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/054495 |
| Data | 2010-04-06 |
| (87) | Numeris | WO 2010/115866 |
| Data | 2010-10-14 |
| (30) | Numeris | Data | Šalis |
| 212004 P | 2009-04-06 | US | |
| 186075 P | 2009-06-11 | US |
| (72) |
STERGAARD, Henrik, DK
PUSATERI, Tony, US
BARNETT, Thomas R., US
BUCHARDT, Jens, DK
PESCHKE, Bernd, DK
KOFOD-HANSEN, Mikael, DK
ZUNDEL, Magali A., DK
BEHRENS, Carsten, DK
OLSEN, Eva H. Norling, DK
STENNICKE, Henning, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS |
| TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS |